Clinical Characteristics and Outcomes of Pregnant Women Confirmed with SARS-COV-2 Admitted in the Hospitals in Baghdad
Background: Pregnant women are considered one of the most vulnerable groups for COVID-19. Routine but essential services are the most affected during emergencies, therefore practitioners must pay closer attention to women and newborns to minimise the impact of the pandemic on these vulnerable populations.
Objectives: To describe clinical characteristics and outcomes of pregnant women admitted to hospitals with SARS-CoV-2 in Baghdad during 2020.
Methods: Across-sectional retrospective study was conducted in six maternity hospitals in Baghdad during a period of ten months, including 170 pregnant ladies who came to the hospital for labour or management of health problems related to pregnancy and testedpositive for COVID-19. The data were collected from medical records and patient medical sheets of admitted ladies, phone calls, and questionnaires.
Results: The mean age of the included women was 29.59±6.78 years, and 50.6% of patients were aged less than 30 years with 41.2% having primary education level. 78.2% of patients were housewives, 94.7% of pregnant women had a single foetus, 84.7% delivered by caesarean section, 58.2% reported fever as the most common symptom, and 43.5% of neonates of mothers with COVID-19 had a negative test result of COVID-19.
Conclusion: The majority of pregnant ladies were symptomatic and hypertension was the most common co-morbidity in the included pregnant ladies. There was a significant association between age and the presence of symptoms of COVID-19 infection in which patients aged less than thirty years who presented with symptoms, especially fever and dyspnoea were more than patients aged thirty years old or more.
How to cite this article:
Hussain NA, Al-Khazrajy LA. Clinical Characteristics and Outcomes of Pregnant Women Confirmed with SARS-COV-2 Admitted in the Hospitals in Baghdad. J Commun Dis. 2022;54(1):15-21.
Centers for Disease Control and Prevention (CDC) [Internet]. Basics of COVID-19; 2021 [cited 2021 May 24]. Available from:https:// www.cdc.gov/coronavirus/2019-ncov/cdcresponse/about-COVID-19.html
World Health Organization (WHO) [Internet]. Weekly epidemiological update;2020 Dec29[cited 2021 Jan 2]. Available from: https://www.who.int/ publications/m/item/weekly-epidemiologicalupdate---29-december-2020
Bethany K. How COVID-19 threatens maternal and child health in low- and middle-income countries [Internet]. Maternal Health Task Force; 2020 Jun 25 [cited 2021 May 24]. Available from: https://www.mhtf.org/2020/06/25/how-covid-19-threatens-maternaland-child-health-in-low-and-middle-income-countries/
Vora KS, Sundararajan A, Saiyed S, Dhama K, Natesan S. Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development. Hum Vaccin Immunother. 2020;16(12):2932-7. [PubMed] [Google Scholar]
Pan American Health Organization[Internet]. PAHO reports more than 60,000 confirmed cases of COVID-19 in pregnant women with 458 deaths; 2020 Sep 22 [cited 2021 Jan 2]. Available from:https://www.paho.org/en/news/22-9-2020-paho-reports-more-60000-confirmedcases-covid-19-pregnant-women-458-deaths
Huaxia. Iraq announces 1st case of COVID-19 in Najaf. Xinhua. 2020 Jul 14;19(18):45.
Al-Kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Musa RA, Ali ZH. COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery. Asian Pac J Reprod. 2020;9(3):156-8. [Google Scholar]
Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, Roggero P, Prefumo F, do Vale MS, Cardona-Perez JA, Maiz N, Cetin I, Savasi V, Deruelle P, Easter SR, Sichitiu J, Conti CP, Ernawati E, Mhatre M, Teji JS, Liu B, Capelli C, Oberto M, Salazar L, Gravett MG, Cavoretto PI, Nachinab VB, Galadanci H, Oros D, Ayede AI, Sentilhes L, Bako B, Savorani M, Cena H, García-May PK, Etuk S, Casale R, Abd-Elsalam S, Ikenoue S, Aminu MB, Vecciarelli C, Duro EA, Usman MA, John-Akinola Y, Nieto R, Ferrazi E, Bhutta ZA, Langer A, Kennedy SH, Papageorghiou AT. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection:the INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817-26. [PubMed] [Google Scholar]
Api O, Sen C, Debska M, Saccone G, D’Antonio F, Volpe N, Yayla M, Esin S, Turan S, Kurjak A, Chervenak F. Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM World Association of Perinatal Medicine. J Perinat Med. 2020;48(9):857-66. [PubMed] [Google Scholar]
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15. [PubMed] [Google Scholar]
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand.2020;99(7):823-9. [PubMed] [Google Scholar]
Martinez-PortillaRJ,Torres J, Basurto D, Jimenez VM. The interwoven effect of maternal age and co-morbidities in COVID-19 fatality among pregnant women: the Mexican national cohort. Ultrasound Obs Gynecol. 2020;56(S1):11-12.[Google Scholar]
Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, Zhou W. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020 Jul 1;174(7):722-5. [PubMed] [Google Scholar]
Mascio DD, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V, D’Antonio F. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. [PubMed] [Google Scholar]
Patil PP, Maru S, Krishnan P, Carroll-Bennett R, Sanchez J, Noble L, WassermanR. Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic’s epicenter. J Perinatol.2020;40(10):1455-8. [PubMed] [Google Scholar]
Copyright (c) 2022 Open Access
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.